Your browser doesn't support javascript.
loading
[Faecal calprotectin in inflammatory bowel disease: Review]
Tunisie Medicale [La]. 2011; 89 (5): 425-429
em Francês | IMEMR | ID: emr-133344
ABSTRACT
The clinical course of inflammatory bowel disease [IBD] is characterized by a succession of relapses and remissions. A regular and a long term monitoring of such patients is required. Faecal markers, especially calprotectin's use, seem to be useful in these patients. Faecal calprotectin is a reliable maker of intestinal inflammation in IBD. Its level is assessed by a simple and a non invasive test. We proposed to review main indications and study results of faecal calprotectin test use in IBD patients. Review of literature. Faecal calprotectin assessment isn't an IBD specific test. Selective use is required to have a good benefit-cost ratio. Prediction of relapses in asymptomatic patients as well as post operative reccurence seems to be the main indications for its use. Mucosal healing assessment after anti-TNF treatment can also be an interesting indication although it isn't well evaluated
Buscar no Google
Índice: IMEMR (Mediterrâneo Oriental) Idioma: Francês Revista: Tunisie Med. Ano de publicação: 2011

Similares

MEDLINE

...
LILACS

LIS

Buscar no Google
Índice: IMEMR (Mediterrâneo Oriental) Idioma: Francês Revista: Tunisie Med. Ano de publicação: 2011